Another study employing a mouse CIA model revealed that EGCG (administered intraperitoneally daily at 20 mg/kg) ameliorated arthritis and macrophage infiltration while reducing the number of osteoblasts synthesizing MCP-1/CCL2 [29]. This evidence concerns the gene CCL2 and arthritic joint disease.